Research programme: HIV vaccines - Cerus/Fred Hutchinson Cancer Research Center
Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Cerus Corporation; Fred Hutchinson Cancer Research Center
- Class AIDS vaccines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in USA
- 08 Mar 2007 Preclinical trials in HIV infections prevention in USA (unspecified route)